A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"
- Status
- RECRUITING
- Phase
- N/A
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
- Status
- COMPLETED
- Phase
- N/A
Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Pediatric Pertussis in Ambulatory Settings
- Status
- RECRUITING
- Phase
- N/A
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
RSV Burden in Outpatient and Hospital Settings
- Status
- RECRUITING
- Phase
- NA
Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease
- Status
- COMPLETED
- Phase
- NA
Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy
- Status
- UNKNOWN
- Phase
- N/A